Clinical Metabolomics


Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.



 


    Related Conference of Clinical Metabolomics

    September 27-28, 2022

    26th European Biotechnology Congress

    Paris, France
    October 10-11, 2022

    International Conference on Biosimilars & Pharmaceuticals

    Amsterdam, Netherlands
    October 24-25, 2022

    5th International Conference on Glycobiology

    Paris, France
    October 27-28, 2022

    2nd Annual Summit on Advanced Bionics

    Rome, Italy
    November 14-15, 2022

    4th International Conference on Biochemistry

    London, UK
    November 14-15, 2022

    4th International Conference on Nucleic Acids

    London, UK
    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy

    Clinical Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in